The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Origin, maturation and antigen presenting function of dendritic cells
Cella, M., Sallusto, F., & Lanzavecchia, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80153-7 · Cited by 1,320
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 974
Self-citationType I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?
Romagnani, S. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90083-j · Cited by 780
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Cytokine therapeutics: lessons from interferonalpha.
Gutterman, J. U. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1198 · Cited by 703
Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., & Davis, M. M. (2000) · Nature Medicine · doi:10.1038/79526 · Cited by 672
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 643
Self-citationType I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N. J., Trapani, J., & Cebon, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1947 · Cited by 611
Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon
Gogas, H., Ioannovich, J., Dafni, U., Stavropoulou-Giokas, C., Frangia, K., Tsoutsos, D., Panagiotou, P., Polyzos, A., Papadopoulos, O., Stratigos, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053007 · Cited by 566
Prognostic significance of autoimmunity during treatment of melanoma with interferon
Krauze, M. T., Tarhini, A., Gogas, H., & Kirkwood, J. M. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0247-y · Cited by 507
Chronic Myelogenous Leukemia: Biology and Therapy
Faderl, S., Talpaz, M., Estrov, Z., & Kantarjian, H. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00008 · Cited by 462
Sanderson, K., Scotland, R., Lee, P., Liu, D., Groshen, S., Snively, J., Sian, S., Nichol, G., Davis, T., Keler, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.128 · Cited by 434
Pardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
Type I Interferon-mediated Stimulation of T Cells by CpG DNA
Sun, S., Zhang, X., Tough, D. F., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2335 · Cited by 361
Interferon-alpha in tumor immunity and immunotherapy
Belardelli, F., Ferrantini, M., Proietti, E., & Kirkwood, J. M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00022-3 · Cited by 337
Self-citationMihm, M. C., Clemente, C. G., & Cascinelli, N. (1996) · PubMed · Cited by 318
The neglected role of type I interferon in the T-cell response: implications for its clinical use
Belardelli, F., & Gresser, I. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10027-x · Cited by 299
Self-citationStrategies for global control of cervical cancer
Pontén, J., Adami, H., Bergström, R., Dillner, J., Friberg, L., Gustafsson, L., Miller, A. B., Parkin, D. M., Sparén, P., & Trichopoulos, D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600102 · Cited by 289
Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P. J., & Julkunen, I. (1999) · Blood · doi:10.1182/blood.v93.6.1980.406k20_1980_1991 · Cited by 278
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business
Mogensen, K. E., Lewerenz, M., Reboul, J., Lutfalla, G., & Uzé, G. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313019 · Cited by 252
Moschos, S. J., Edington, H. D., Land, S. R., Rao, U. N., Jukic, D., Shipe-Spotloe, J., & Kirkwood, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2498 · Cited by 242
Zarour, H. M., Kirkwood, J. M., Kierstead, L. S., Herr, W., Brusić, V., Slingluff, C. L., Sidney, J., Sette, A., & Storkus, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.400 · Cited by 162
Cytokines, tumour-cell death and immunogenicity: a question of choice
Musiani, P., Modesti, A., Giovarelli, M., Cavallo, F., Forni, G., Lollini, P. L., & Colombo, M. P. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80012-6 · Cited by 159
Fifty Years of Interferon Research: Aiming at a Moving Target
Vilček, J. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.008 · Cited by 157
Lapenta, C., Santini, S. M., Spada, M., Donati, S., Urbani, F., Accapezzato, D., Franceschini, D., Andreotti, M., Barnaba, V., & Belardelli, F. (2006) · European Journal of Immunology · doi:10.1002/eji.200535579 · Cited by 147
Self-citationWu, C. J., Yang, X., McLaughlin, S., Neuberg, D. S., Canning, C. M., Stein, B. L., Alyea, E. P., Soiffer, R. J., Dranoff, G., & Ritz, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10196 · Cited by 134
Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Pucchio, T. D., Parlato, S., & Belardelli, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021924 · Cited by 128
Self-citationPucchio, T. D., Pilla, L., Capone, I., Ferrantini, M., Montefiore, E., Urbani, F., Patuzzo, R., Pennacchioli, E., Santinami, M., Cova, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3396 · Cited by 119
Self-citationRadvanyi, Banerjee, Weir, & Messner (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00625.x · Cited by 118
A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α
Horton, H. M., Anderson, D. A., Hernandez, P., Barnhart, K. M., Norman, J. A., & Parker, S. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1553 · Cited by 117
Tosi, D., Valenti, R., Cova, A., Sovena, G., Huber, V., Pilla, L., Arienti, F., Belardelli, F., Parmiani, G., & Rivoltini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5363 · Cited by 93
Self-citationFranzke, A., Peest, D., Probst‐Kepper, M., Buer, J., Kirchner, G. I., Brabant, G. E., Kirchner, H. H., Ganser, A., & Atzpodien, J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.529 · Cited by 87
Santodonato, L., D’Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Perrone, M. P., Andreotti, M., Belardelli, F., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5195 · Cited by 86
Self-citationHåkansson, A., Gustafsson, B., Krysander, L., & Håkansson, L. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.420 · Cited by 86
Autoimmunity and the Immunotherapy of Cancer: Targeting the "Self" to Destroy the "Other"
Overwijk, W. W., & Restifo, N. P. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i6.10 · Cited by 83
The Philadelphia chromosome translocation a paradigm for understanding leukemia
Rowley, J. D. (1990) · Cancer · Cited by 82
IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs
Hiroishi, K., Tüting, T., & Lotze, M. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.567 · Cited by 77
Gabriele, L., Borghi, P., Rozera, C., Sestili, P., Andreotti, M., Guarini, A. R., Montefusco, E., Foà, R., & Belardelli, F. (2003) · Blood · doi:10.1182/blood-2003-03-0981 · Cited by 73
Self-citationFerrantini, M., & Belardelli, F. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0333 · Cited by 72
Self-citationAutoimmunity and Immunotherapy for Cancer
Koon, H. B., & Atkins, M. B. (2006) · New England Journal of Medicine · doi:10.1056/nejme058307 · Cited by 60
Chen, X., Regn, S., Raffegerst, S. H., Kolb, H., & Roskrow, M. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02361.x · Cited by 58
Belardelli, F., Ferrantini, M., Santini, S. M., Baccarini, S., Proietti, E., Colombo, M. P., Sprent, J., & Tough, D. F. (1998) · PubMed · Cited by 50
Self-citationAstsaturov, I. A., Petrella, T. M., Bağrıaçık, E. Ü., de Benedette, M., Uger, R. A., Lumber, G., Berinstein, N. L., Elias, I., Iscoe, N., Hammond, C., et al. (2003) · PubMed · Cited by 48
Håkansson, A., GUSTAFSSON, B., Krysander, L., & Håkansson, L. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.33 · Cited by 40
The antitumor effects of interferon: A personal history
Gresser, I. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.005 · Cited by 34
Hiroishi, K., Tüting, T., Tahara, H., & Lotze, M. T. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301034 · Cited by 30
Mecchia, M., Matarrese, P., Malorni, W., D’Agostino, G., Sestili, P., Santini, S. M., Gauzzi, M. C., Venditti, M., Mazzocchi, A., Parmiani, G., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301059 · Cited by 28
Self-citationTsavaris, N. B., Baxevanis, C. N., Kosmidis, P., & Papamichael, M. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050308 · Cited by 26
Kosmidis, P., Baxevanis, C. N., Tsavaris, N. B., Papanastasiou, M., Anastasopoulos, E., Bacoyiannis, C., Mylonakis, N., Karvounis, N., Bafaloukos, D. I., & Karabelis, A. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1153 · Cited by 19
Fujii, S. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009060316 · Cited by 14
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Immunomodulatory functions of type I interferons
González-Navajas, J. M., Lee, J., David, M., & Raz, E. (2012) · Nature Reviews Immunology · doi:10.1038/nri3133 · Cited by 1,011
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Mechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
Metadata
- Authors
- Ferrantini, M., Capone, I., & Belardelli, F.
- Venue
- Biochimie
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 89
- Issue
- 6-7
- Pages
- 884-893
- ISSN
- 0037-9042 (ISSN-L)
- 0300-9084
- OpenAlex
- W2017153151
- Cited by
- 268
- References
- 63
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.